SCHEMBL26028581

SCHEMBL26028581

C=CCCNCc1cccc(OCC(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 7/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HDAC4 P56524 1/20 0.43
▸ MEF2D Q14814 1/20 0.43
▸ DRD2 P14416 2/20 0.42
▸ DRD4 P21917 1/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ADRA1B P35368 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ HTR1A P08908 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ SCN8A Q9UQD0 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26028368 0.83 POLB (0.41) BCHEDRD4CHRM2SCN8A
SCHEMBL22957720 0.82 BCHE (0.49) BCHEMEN1KMT2AHDAC4MEF2D
SCHEMBL26028493 0.79 SCN8A (0.53) MEN1KMT2AADRA1ADRD3HTR2A
SCHEMBL13074511 0.79 BCHE (0.49) BCHEMEN1KMT2AHDAC4MEF2D
SCHEMBL12228162 0.78 BCHE (0.54) BCHEMEN1KMT2ADRD2CHRM2
SCHEMBL5947203 0.78 KDM4E (0.66) BCHEMEN1KMT2ADRD2HTR1A
SCHEMBL5947542 0.77 BCHE (0.60) BCHEMEN1KMT2ADRD2CHRM2
SCHEMBL5947539 0.77 BCHE (0.56) BCHEMEN1KMT2ADRD2HTR1A
SCHEMBL5947775 0.76 BCHE (0.62) BCHEMEN1KMT2ADRD2HTR1A
SCHEMBL8292121 0.76 MRGPRX4 (0.48) BCHEHDAC4MEF2DCHRM2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154291-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 — — WO disclosed
Send feedback